{"id":7286,"date":"2024-04-08T11:00:17","date_gmt":"2024-04-08T09:00:17","guid":{"rendered":"https:\/\/eu.bd.com\/iv-news\/?p=7286"},"modified":"2024-04-08T11:55:44","modified_gmt":"2024-04-08T09:55:44","slug":"bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv","status":"publish","type":"post","link":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/","title":{"rendered":"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV"},"content":{"rendered":"<p><span data-contrast=\"auto\">Votre source d&#8217;informations sur le traitement intraveineux (IV) s&#8217;am\u00e9liore. Suite aux retours des lecteurs, BD IV News a \u00e9t\u00e9 remani\u00e9 pour mieux servir les professionnels de sant\u00e9 curieux tels que vous qui assurent l\u2019administration des m\u00e9dicaments et <a href=\"https:\/\/lp.bd.com\/vam\">la gestion des acc\u00e8s vasculaires<\/a>.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>Actualisation des informations sur le traitement IV<\/h2>\n<p><span data-contrast=\"auto\">Depuis juin\u202f2020, BD IV News communique aux lecteurs les derni\u00e8res actualit\u00e9s et avanc\u00e9es dans le domaine du traitement IV.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h3>Les articles \u00e9voquent les mises \u00e0 jour dans les domaines suivants\u202f:<\/h3>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Recherche scientifique<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Nouvelles solutions et technologies<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">\u00c9volution des directives et r\u00e9glementations<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">D\u00e9couvrez les bonnes pratiques techniques ax\u00e9es sur la s\u00e9curit\u00e9 des patients et des professionnels de sant\u00e9.<\/span><span data-contrast=\"auto\">\u200b <\/span><span data-contrast=\"auto\">Nous avons pour objectif d&#8217;aider les professionnels de sant\u00e9 \u00e0 prodiguer les meilleurs soins possibles \u00e0 leurs patients.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>Opportunit\u00e9s de d\u00e9veloppement des r\u00e9seaux<\/h2>\n<p><span data-contrast=\"auto\">Participez \u00e0 des webinaires et \u00e0 des \u00e9v\u00e9nements en pr\u00e9sentiel partout en Europe, au Moyen-Orient et en Afrique (EMEA) qui vous permettront d\u2019\u00e9changer avec d&#8217;autres professionnels de sant\u00e9 et d\u2019interagir avec des experts.<\/span><span data-contrast=\"auto\">\u200b<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>Ressources p\u00e9dagogiques<span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\"> pour le traitement IV<\/span><\/h2>\n<p><span data-contrast=\"auto\">Explorez une multitude de supports p\u00e9dagogiques, notamment\u202f:\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><a href=\"https:\/\/eu.bd.com\/iv-news\/fr\/category\/publications-scientifiques\/\"><span data-contrast=\"none\">Publications scientifiques<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Infographies<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><a href=\"https:\/\/eu.bd.com\/iv-news\/fr?s=webinaire\"><span data-contrast=\"none\">Webinaires en replay<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\"><a href=\"https:\/\/eu.bd.com\/iv-news\/fr\/?s=MACOVA\"><span data-contrast=\"none\">Comptes-rendus d\u2019\u00e9v\u00e9nements en pr\u00e9sentiel<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\"><a href=\"https:\/\/eu.bd.com\/iv-news\/fr\/ivpedia\/\"><span data-contrast=\"none\">I.V.p\u00e9dia<\/span><\/a><span data-contrast=\"auto\">\u202f: conseils et informations pour vous aider \u00e0 pr\u00e9venir les complications associ\u00e9es aux cath\u00e9ters intraveineux<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Ces ressources peuvent vous aider \u00e0 am\u00e9liorer vos connaissances et \u00e0 acqu\u00e9rir de nouvelles comp\u00e9tences.<\/span><span data-contrast=\"auto\">\u200b<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h2>Nouveau look, m\u00eame contenu de qualit\u00e9<\/h2>\n<p><span data-contrast=\"auto\">Pr\u00e8s de quatre ans apr\u00e8s le lancement de BD IV News, vos retours nous ont permis de le transformer afin d&#8217;am\u00e9liorer votre exp\u00e9rience de lecteur. Une nouvelle mise en page facilite la navigation sur le site Web<\/span><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h3>Des fonctionnalit\u00e9s am\u00e9lior\u00e9es que vous appr\u00e9cierez\u202f:<\/h3>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\"><span data-contrast=\"auto\">Navigation am\u00e9lior\u00e9e<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"7\" data-aria-level=\"1\"><span data-contrast=\"auto\">Barre de progression de la lecture<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"8\" data-aria-level=\"1\"><span data-contrast=\"auto\">Apparence \u00e9pur\u00e9e et contemporaine<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"9\" data-aria-level=\"1\"><span data-contrast=\"auto\">Mises \u00e0 jour des boutons de partage sur les r\u00e9seaux sociaux<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"10\" data-aria-level=\"1\"><span data-contrast=\"auto\">Plus adapt\u00e9 aux mobiles<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<h2>C&#8217;est maintenant \u00e0 vous de choisir<\/h2>\n<p><span data-contrast=\"auto\">Apr\u00e8s avoir cr\u00e9\u00e9 votre profil de lecteur, vous pouvez s\u00e9lectionner vos centres d&#8217;int\u00e9r\u00eat et votre profession. Ensuite, \u00e0 chaque visite sur le site Web, vous aurez acc\u00e8s aux contenus les plus r\u00e9cents et les plus pertinents pour vous. Cr\u00e9ez votre profil personnalis\u00e9 d\u00e8s aujourd\u2019hui.<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\"><div class=\"su-button-center\"><a href=\"https:\/\/eu.bd.com\/iv-news\/fr\/inscription\/\" class=\"su-button su-button-style-default\" style=\"color:#FFFFFF;background-color:#2D89EF;border-color:#246ec0;border-radius:6px\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color:#FFFFFF;padding:0px 18px;font-size:14px;line-height:28px;border-color:#6cadf4;border-radius:6px;text-shadow:none\"> REJOIGNEZ LA COMMUNAUT\u00c9 BD IV NEWS<\/span><\/a><\/div>\u00a0<\/span><\/p>\n<h2>Des contenus exclusifs sur le traitement IV<\/h2>\n<p><span data-contrast=\"auto\">Vous aurez acc\u00e8s \u00e0 des ressources et \u00e0 des contenus exclusifs avec votre profil de lecteur. De temps en temps, vous recevrez des invitations \u00e0 des \u00e9v\u00e9nements priv\u00e9s, tels que des s\u00e9ances de questions-r\u00e9ponses en direct sur des sujets li\u00e9s au traitement IV.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Comme indiqu\u00e9 ci-dessus, ce remaniement est le r\u00e9sultat des retours des lecteurs. Merci de continuer \u00e0 nous faire part de vos impressions pour nous permettre d&#8217;am\u00e9liorer encore votre exp\u00e9rience de lecteur.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Votre source d&#8217;informations sur le traitement intraveineux (IV) s&#8217;am\u00e9liore. Suite aux retours des lecteurs, BD IV News a \u00e9t\u00e9 remani\u00e9&#8230;<\/p>\n","protected":false},"author":8,"featured_media":7288,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[748],"tags":[],"class_list":["post-7286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites-et-innovation","speciality-abord-vasculaire","speciality-anesthesie","speciality-covid-19-fr","speciality-economie-de-la-sante","speciality-equipe-operationnelle-dhygiene","speciality-oncologie-medicale","speciality-pediatrie","speciality-preparation-de-medicaments","speciality-securite-des-soignants","speciality-securite-du-patient","speciality-soins-a-domicile","speciality-soins-intensifs-soins-durgence","contenttype-article-fr","target-approvisionnement","target-directeur-responsable-dhopital","target-equipe-operationnelle-dhygiene","target-medecin","target-medecine-du-travail","target-patient-fr","target-pharmacie-clinique","target-soins-infirmiers"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV - BD IV News<\/title>\n<meta name=\"description\" content=\"Ce site d\u2019information sur le traitement IV a \u00e9t\u00e9 remani\u00e9 afin d&#039;am\u00e9liorer l\u2019exp\u00e9rience des lecteurs. D\u00e9couvrez-le et rejoignez la communaut\u00e9\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV - BD IV News\" \/>\n<meta property=\"og:description\" content=\"Ce site d\u2019information sur le traitement IV a \u00e9t\u00e9 remani\u00e9 afin d&#039;am\u00e9liorer l\u2019exp\u00e9rience des lecteurs. D\u00e9couvrez-le et rejoignez la communaut\u00e9\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/\" \/>\n<meta property=\"og:site_name\" content=\"BD IV News\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-08T09:00:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-08T09:55:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/01\/BD-IV-News-IV-therapy-community.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"994\" \/>\n\t<meta property=\"og:image:height\" content=\"423\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Camille Suarez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Camille Suarez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/\"},\"author\":{\"name\":\"Camille Suarez\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/133274b3c3f2b1e2a25492760340ccf2\"},\"headline\":\"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV\",\"datePublished\":\"2024-04-08T09:00:17+00:00\",\"dateModified\":\"2024-04-08T09:55:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/\"},\"wordCount\":512,\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/BD-IV-News-IV-therapy-community.jpg\",\"articleSection\":[\"Actualit\u00e9s et innovation\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/\",\"name\":\"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV - BD IV News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/BD-IV-News-IV-therapy-community.jpg\",\"datePublished\":\"2024-04-08T09:00:17+00:00\",\"dateModified\":\"2024-04-08T09:55:44+00:00\",\"description\":\"Ce site d\u2019information sur le traitement IV a \u00e9t\u00e9 remani\u00e9 afin d'am\u00e9liorer l\u2019exp\u00e9rience des lecteurs. D\u00e9couvrez-le et rejoignez la communaut\u00e9\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/actualites-et-innovation\\\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/BD-IV-News-IV-therapy-community.jpg\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/BD-IV-News-IV-therapy-community.jpg\",\"width\":994,\"height\":423,\"caption\":\"Les lecteurs de BD IV News forment d\u00e9sormais une communaut\u00e9 sur le traitement IV.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"name\":\"BD IV News\",\"description\":\"Your source of information on intravenous therapy, medication delivery and vascular access management.\",\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\",\"name\":\"BD IV News\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"width\":512,\"height\":512,\"caption\":\"BD IV News\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/133274b3c3f2b1e2a25492760340ccf2\",\"name\":\"Camille Suarez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g\",\"caption\":\"Camille Suarez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV - BD IV News","description":"Ce site d\u2019information sur le traitement IV a \u00e9t\u00e9 remani\u00e9 afin d'am\u00e9liorer l\u2019exp\u00e9rience des lecteurs. D\u00e9couvrez-le et rejoignez la communaut\u00e9","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/","og_locale":"en_GB","og_type":"article","og_title":"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV - BD IV News","og_description":"Ce site d\u2019information sur le traitement IV a \u00e9t\u00e9 remani\u00e9 afin d'am\u00e9liorer l\u2019exp\u00e9rience des lecteurs. D\u00e9couvrez-le et rejoignez la communaut\u00e9","og_url":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/","og_site_name":"BD IV News","article_published_time":"2024-04-08T09:00:17+00:00","article_modified_time":"2024-04-08T09:55:44+00:00","og_image":[{"width":994,"height":423,"url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/01\/BD-IV-News-IV-therapy-community.jpg","type":"image\/jpeg"}],"author":"Camille Suarez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Camille Suarez","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/#article","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/"},"author":{"name":"Camille Suarez","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/133274b3c3f2b1e2a25492760340ccf2"},"headline":"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV","datePublished":"2024-04-08T09:00:17+00:00","dateModified":"2024-04-08T09:55:44+00:00","mainEntityOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/"},"wordCount":512,"publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/01\/BD-IV-News-IV-therapy-community.jpg","articleSection":["Actualit\u00e9s et innovation"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/","url":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/","name":"BD IV News 2.0\u202f: cr\u00e9er une communaut\u00e9 sur le traitement IV - BD IV News","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/#primaryimage"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/01\/BD-IV-News-IV-therapy-community.jpg","datePublished":"2024-04-08T09:00:17+00:00","dateModified":"2024-04-08T09:55:44+00:00","description":"Ce site d\u2019information sur le traitement IV a \u00e9t\u00e9 remani\u00e9 afin d'am\u00e9liorer l\u2019exp\u00e9rience des lecteurs. D\u00e9couvrez-le et rejoignez la communaut\u00e9","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/fr\/actualites-et-innovation\/bd-iv-news-2-0-creer-une-communaute-sur-le-traitement-iv\/#primaryimage","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/01\/BD-IV-News-IV-therapy-community.jpg","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/01\/BD-IV-News-IV-therapy-community.jpg","width":994,"height":423,"caption":"Les lecteurs de BD IV News forment d\u00e9sormais une communaut\u00e9 sur le traitement IV."},{"@type":"WebSite","@id":"https:\/\/eu.bd.com\/iv-news\/#website","url":"https:\/\/eu.bd.com\/iv-news\/","name":"BD IV News","description":"Your source of information on intravenous therapy, medication delivery and vascular access management.","publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eu.bd.com\/iv-news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/eu.bd.com\/iv-news\/#organization","name":"BD IV News","url":"https:\/\/eu.bd.com\/iv-news\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","width":512,"height":512,"caption":"BD IV News"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/133274b3c3f2b1e2a25492760340ccf2","name":"Camille Suarez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g","caption":"Camille Suarez"}}]}},"lang":"fr","translations":{"fr":7286,"en":6992,"de":7312,"it":7352,"es":7530},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/7286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/comments?post=7286"}],"version-history":[{"count":8,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/7286\/revisions"}],"predecessor-version":[{"id":7750,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/7286\/revisions\/7750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media\/7288"}],"wp:attachment":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media?parent=7286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/categories?post=7286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/tags?post=7286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}